𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serum phytoestrogens and prostate cancer risk in a nested case-control study among Japanese men

✍ Scribed by Kotaro Ozasa; Masahiro Nakao; Yoshiyuki Watanabe; Kyohei Hayashi; Tsuneharu Miki; Kazuya Mikami; Mitsuru Mori; Fumio Sakauchi; Masakazu Washio; Yoshinori Ito; Koji Suzuki; Kenji Wakai; Akiko Tamakoshi


Book ID
108582388
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
245 KB
Volume
95
Category
Article
ISSN
1347-9032

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Serum estrogen levels and prostate cance
✍ Song Yao; Cathee Till; Alan R. Kristal; Phyllis J. Goodman; Ann W. Hsing; Cather πŸ“‚ Article πŸ“… 2011 πŸ› Springer Netherlands 🌐 English βš– 190 KB

## Objective Finasteride reduces prostate cancer risk by blocking the conversion of testosterone to dihydrotestosterone. However, whether finasteride affects estrogens levels or change in estrogens affects prostate cancer risk is unknown. ## Methods These questions were investigated in a case–con

Circulating enterolactone and prostate c
✍ PΓ€r Stattin; Herman Adlercreutz; Leena Tenkanen; Egil Jellum; Sonja Lumme; GΓΆran πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 84 KB πŸ‘ 2 views

## Abstract Enterolactone, a phytoestrogen belonging to the class of lignans, is produced by the intestinal microflora from precursors in plant foods and has been implicated in protection against cancer. We study the effect of enterolactone on the risk of a subsequent diagnosis of prostate cancer.